Daniel D. Burton, Chief Executive Officer at Health Catalyst, Inc. (HCAT), sold 43,218 shares at $35.96 ($1.5M) on 2020-12-02, disclosed to the SEC on 2020-12-03.
Open-market sale of $1.5M HCAT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.98 | 4,482 | $157K | 10.3% |
| 2 | $34.98 | 4,482 | $157K | 10.3% |
| 3 | $35.01 | 12,391 | $434K | 28.5% |
| 4 | $35.01 | 12,391 | $434K | 28.5% |
| 5 | $35.96 | 4,736 | $170K | 11.2% |
| 6 | $35.96 | 4,736 |
| $170K |
| 11.2% |
| Total | $35.21 avg | 43,218 | $1.5M | 100% |
| Filing → |
| HCAT | BUY | 2022-11-14 | $4.0M | — | Filing → |
| HCAT | BUY | 2022-09-08 | $2.0M | — | Filing → |
| HCAT | BUY | 2022-08-09 | $4.1M | — | Filing → |